Vita Life Sciences (ASX: VLS) — Perfil da empresa, notícias e dados financeiros
Vita Life Sciences is a pharmaceutical and healthcare company engaged in the development, formulation, and distribution of vitamins, dietary supplements, minerals, herbal formulas, and over-the-counter health products.
Vita Life Sciences
Vita Life Sciences is a pharmaceutical and healthcare company engaged in the development, formulation, and distribution of vitamins, dietary supplements, minerals, herbal formulas, and over-the-counter health products. The company operates across Australia and key Asian markets, including Malaysia, Singapore, Thailand, Vietnam, Indonesia, and China. Its core brand portfolio features established health brands such as Herbs of Gold, VitaHealth, VitaScience, and VitaLife, encompassing more than 350 health and wellness products. Vita Life Sciences formulates its product range through specialized teams of naturopaths, nutritionists, biotechnologists, and pharmacists to serve consumers across diverse age groups and health conditions.
Resumo
Operações
Produtos e/ou serviços de Vita Life Sciences
- Herbs of Gold: Premium complementary medicine brand distributed primarily through health food stores and pharmacies in Australia and Asian markets, offering specialized therapeutic herbal formulas, vitamins, minerals, and targeted nutritional supplements for various health conditions.
- VitaHealth: Established healthcare and dietary supplement brand providing a broad range of vitamins, minerals, and functional health formulations distributed across retail pharmacies, health chains, and direct channels throughout Southeast Asian markets.
- VitaScience: Range of pharmacy-exclusive and specialized dietary supplements engineered for specific clinical applications and targeted therapeutic needs, distributed through professional pharmacy networks and healthcare retail channels across domestic and regional international markets.
- VitaLife: Mass-market complementary healthcare brand delivering daily nutritional supplements, general health formulations, and lifestyle wellness products targeted at broad consumer segments across retail distribution networks in key operating territories.
- Australian Regional Operations: Domestic commercial division managing the formulation, warehousing, marketing, and multi-channel distribution of dietary supplement brands to pharmacy chains, independent pharmacies, health food stores, and digital channels across Australia.
- Asian Regional Operations: International commercial division managing product registration, import distribution, and local retail operations across major Asian growth markets, including established distribution networks in Malaysia, Singapore, Thailand, Vietnam, Indonesia, and China.
equipe executiva do Vita Life Sciences
- Andrew W. O'KeefeMD & Director
- Chin Leng KhooCFO & Company Secretary
- Melissa PereiraHead of Marketing
- Shaun RutherfordChief Executive Officer of Herbs of Gold Australia
- K. S. BehChief Executive Officer of Vita Life Sciences Malaysia & Singapore
Últimas notícias sobre a Vita Life Sciences
Comunicados recentes
O que a Vita Life Sciences (VLS) comunicou ao mercado, do mais recente para o mais antigo.
- Notification of cessation of securities - VLS
- Change of Director's Interest Notice
- Update - Notification of buy-back - VLS
- Update - Notification of buy-back - VLS
- Update - Notification of buy-back - VLS
- Cleasing Statement
- Application for quotation of securities - VLS
Histórico de dividendos
Dividendos por ação pagos pela Vita Life Sciences, por ano fiscal.
| Ano fiscal | Intermediário | Final | Especial | Total |
|---|---|---|---|---|
| FY2026(até o momento) | A$0.0950 | A$0.0500 | — | A$0.1450 |
| FY2025 | A$0.0650 | A$0.0450 | — | A$0.1100 |
| FY2024 | A$0.0600 | A$0.0350 | — | A$0.0950 |
| FY2023 | A$0.0325 | A$0.0300 | — | A$0.0625 |
| FY2022 | A$0.0300 | A$0.0275 | — | A$0.0575 |
Principais indicadores financeiros
Resultados divulgados pela Vita Life Sciences, em AUD.
- Cap. de mercado
- 147,7 mi
- Receita (TTM)
- 96 mi
- P/L
- 13.7
- LPA (diluído, TTM)
- 0.2
- Dividend yield
- 5.3%
- Margem de lucro
- 11.6%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 93,3 mi | 14,7 mi | 10,4 mi | |
| 79,5 mi | 11,7 mi | 8,8 mi | |
| 74,2 mi | 12,2 mi | 9,1 mi | |
| 66,9 mi | 11 mi | 7,1 mi |